Logos Global Management LP
68 holdingsFiling period: 2026-06-30Current AUM: $1.92Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ERAS | Erasca Inc | 12.15M | $222.6M | $174.4M | 9.08% | +1.00M | 2026-06-30 |
| 2 | ABVX | Abivax SA | 1.02M | $136.5M | $88.7M | 4.62% | +349.0K | 2026-06-30 |
| 3 | RVMD | Revolution Medicines Inc | 700.0K | $131.1M | $133.9M | 6.98% | -1,300,000 | 2026-06-30 |
| 4 | IDYA | Ideaya Biosciences Inc | 3.00M | $111.8M | $95.9M | 4.99% | -450,000 | 2026-06-30 |
| 5 | BNTX | Biontech SE | 1.01M | $94.4M | $89.5M | 4.66% | -- | 2026-06-30 |
| 6 | VERA | Vera Therapeutics Inc | 2.20M | $94.4M | $68.2M | 3.55% | -- | 2026-06-30 |
| 7 | TNGX | Tango Therapeutics Inc | 2.85M | $89.1M | $64.8M | 3.37% | -150,000 | 2026-06-30 |
| 8 | PRAX | Praxis Precision Medicines I | 260.0K | $87.0M | $74.3M | 3.87% | -25,000 | 2026-06-30 |
| 9 | CLDX | Celldex Therapeutics Inc New | 2.10M | $78.1M | $63.2M | 3.29% | +1.65M | 2026-06-30 |
| 10 | DNTH | Dianthus Therapeutics Inc | 800.0K | $78.0M | $65.9M | 3.43% | +400.0K | 2026-06-30 |
| 11 | CGON | CG Oncology Inc | 1.00M | $71.0M | $64.7M | 3.37% | +425.0K | 2026-06-30 |
| 12 | IRON | Disc Medicine Inc | 875.0K | $64.0M | $70.7M | 3.68% | +315.0K | 2026-06-30 |
| 13 | MAZE | Maze Therapeutics Inc | 1.94M | $57.7M | $60.9M | 3.17% | +700.0K | 2026-06-30 |
| 14 | DYN | Dyne Therapeutics Inc | 2.55M | $56.6M | $42.6M | 2.22% | +1.15M | 2026-06-30 |
| 15 | MLTX | Moonlake Immunotherapeutics | 2.67M | $52.1M | $31.5M | 1.64% | +1.18M | 2026-06-30 |
| 16 | OCUL | Ocular Therapeutix Inc | 5.30M | $52.0M | $36.9M | 1.92% | +1.45M | 2026-06-30 |
| 17 | DSGN | Design Therapeutics Inc | 3.00M | $43.4M | $32.0M | 1.67% | +1.05M | 2026-06-30 |
| 18 | OLMA | Olema Pharmaceuticals Inc | 3.21M | $40.1M | $22.5M | 1.17% | -- | 2026-06-30 |
| 19 | BLTE | Belite Bio Inc | 250.0K | $38.5M | $38.7M | 2.02% | -- | 2026-06-30 |
| 20 | ACHV | Achieve Life Science Inc | 5.42M | $35.4M | $37.1M | 1.93% | -- | 2026-06-30 |
| 21 | TRVI | Trevi Therapeutics Inc | 1.88M | $35.1M | $25.5M | 1.33% | -520,000 | 2026-06-30 |
| 22 | COGT | Cogent Biosciences Inc | 900.0K | $34.8M | $27.9M | 1.45% | -- | 2026-06-30 |
| 23 | AVBP | Arrivent Biopharma Inc | 1.00M | $34.7M | $14.9M | 0.77% | +650.0K | 2026-06-30 |
| 24 | — | Crescent Biopharma Inc. | 1.90M | $34.2M | $34.2M | 1.78% | +1.42M | 2026-06-30 |
| 25 | CMPS | Compass Pathways PLC | 2.25M | $31.8M | $26.0M | 1.36% | -- | 2026-06-30 |
← Scroll →
Page 1 of 3